{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T17:59:53Z","timestamp":1649181593158},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T00:00:00Z","timestamp":1258502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s00108-009-2464-1","type":"journal-article","created":{"date-parts":[[2009,11,16]],"date-time":"2009-11-16T14:42:25Z","timestamp":1258382545000},"page":"1358-1368","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostik und Therapie der Hepatitis"],"prefix":"10.1007","volume":"50","author":[{"given":"C.P.","family":"Strassburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cornberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,11,18]]},"reference":[{"key":"2464_CR1","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1053\/jhep.2003.50106","volume":"37","author":"Berg","year":"2003","unstructured":"Berg T, Sarrazin C, Herrmann E et al. (2003) Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy. Hepatology 37: 600\u2013609","journal-title":"Hepatology"},{"key":"2464_CR2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"Chen","year":"2006","unstructured":"Chen CJ, Yang HI, Su J et al. (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295: 65\u201373","journal-title":"JAMA"},{"key":"2464_CR3","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.bpg.2008.11.003","volume":"22","author":"Chien","year":"2008","unstructured":"Chien RN, Liaw YF (2008) Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success. Best Pract Res Clin Gastroenterol 22: 1081\u20131092","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2464_CR4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1055\/s-2007-963232","volume":"45","author":"Cornberg","year":"2007","unstructured":"Cornberg M, Protzer U, Dollinger MM et al. (2007) Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021\/011. Z Gastroenterol 45: 525\u2013574","journal-title":"Z Gastroenterol"},{"key":"2464_CR5","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa0707615","volume":"359","author":"Di","year":"2008","unstructured":"Di Bisceglie AM, Shiffman ML, Everson GT et al. (2008) Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med 359: 2429\u20132441","journal-title":"N Engl J Med"},{"key":"2464_CR6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/hep.1840400418","volume":"40","author":"Di","year":"2004","unstructured":"Di Marco V, Marzano A, Lampertico P et al. (2004) Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine. Hepatology 40: 883\u2013891","journal-title":"Hepatology"},{"key":"2464_CR7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1055\/s-2003-39648","volume":"41","author":"Erhardt","year":"2003","unstructured":"Erhardt A, Knuth R, Sagir A et al. (2003) Socioepidemiological data on hepatitis delta in a German university clinic\u2013increase in patients from Eastern Europe and the former Soviet Union. Z Gastroenterol 41: 523\u2013526","journal-title":"Z Gastroenterol"},{"key":"2464_CR8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","volume":"50","author":"European","year":"2009","unstructured":"European Association for the Study of the Liver (2009) EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 50: 227\u2013242","journal-title":"J Hepatol"},{"key":"2464_CR9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1086\/381671","volume":"38","author":"Fiore","year":"2004","unstructured":"Fiore AE (2004) Hepatitis A transmitted by food. Clin Infect Dis 38: 705\u2013715","journal-title":"Clin Infect Dis"},{"key":"2464_CR10","doi-asserted-by":"crossref","unstructured":"Hadem J, Wedemeyer H, Manns MP (2004) Hepatitis als Reisekrankheit. Internist (Berl) 45: 655\u2013668","DOI":"10.1007\/s00108-004-1197-4"},{"key":"2464_CR11","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa021812","volume":"348","author":"Hadziyannis","year":"2003","unstructured":"Hadziyannis SJ, Tassopoulos NC, Heathcote EJ et al. (2003) Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med 348: 800\u2013807","journal-title":"N Engl J Med"},{"key":"2464_CR12","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1086\/593335","volume":"198","author":"Hammitt","year":"2008","unstructured":"Hammitt LL, Bulkow L, Hennessy TW et al. (2008) Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults. J Infect Dis 198: 1776\u20131782","journal-title":"J Infect Dis"},{"key":"2464_CR13","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/j.1600-6143.2008.02286.x","volume":"8","author":"Kamar","year":"2008","unstructured":"Kamar N, Mansuy JM, Cointault O et al. (2008) Hepatitis E virus-related cirrhosis in kidney \u2013 and kidney-pancreas-transplant recipients. Am J Transplant 8: 1744\u20131748","journal-title":"Am J Transplant"},{"key":"2464_CR14","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa051287","volume":"354","author":"Lai","year":"2006","unstructured":"Lai CL, Shouval D, Lok AS et al. (2006) Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med 354: 1011\u20131020","journal-title":"N Engl J Med"},{"key":"2464_CR15","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa043470","volume":"352","author":"Lau","year":"2005","unstructured":"Lau GK, Piratvisuth T, Luo KX et al. (2005) Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med 352: 2682\u20132695","journal-title":"N Engl J Med"},{"key":"2464_CR16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/oxfordjournals.aje.a114093","volume":"122","author":"Lednar","year":"1985","unstructured":"Lednar WM, Lemon SM, Kirkpatrick JW et al. (1985) Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol 122: 226\u2013233","journal-title":"Am J Epidemiol"},{"key":"2464_CR17","unstructured":"Lewis HC, Wichmann O, Duizer E (2009) Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic review. Epidemiol Infect 1\u201322"},{"key":"2464_CR18","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.gastro.2008.10.026","volume":"136","author":"Liaw","year":"2009","unstructured":"Liaw YF, Gane E, Leung N et al. (2009) 2-Year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B. Gastroenterology 136: 486\u2013495","journal-title":"Gastroenterology"},{"key":"2464_CR19","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","volume":"351","author":"Liaw","year":"2004","unstructured":"Liaw YF, Sung JJ, Chow WC et al. (2004) Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351: 1521\u20131531","journal-title":"N Engl J Med"},{"key":"2464_CR20","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/gut.2005.076646","volume":"55","author":"Manns","year":"2006","unstructured":"Manns MP, Wedemeyer H, Cornberg M (2006) Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55: 1350\u20131359","journal-title":"Gut"},{"key":"2464_CR21","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa020681","volume":"348","author":"Marcellin","year":"2003","unstructured":"Marcellin P, Chang TT, Lim SG et al. (2003) Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 348: 808\u2013816","journal-title":"N Engl J Med"},{"key":"2464_CR22","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa0802878","volume":"359","author":"Marcellin","year":"2008","unstructured":"Marcellin P, Heathcote EJ, Buti M et al. (2008) Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med 359: 2442\u20132455","journal-title":"N Engl J Med"},{"key":"2464_CR23","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa040431","volume":"351","author":"Marcellin","year":"2004","unstructured":"Marcellin P, Lau GK, Bonino F et al. (2004) Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B. N Engl J Med 351: 1206\u20131217","journal-title":"N Engl J Med"},{"key":"2464_CR24","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1055\/s-0028-1109148","volume":"47","author":"Potthoff","year":"2009","unstructured":"Potthoff A, Rifai K, Wedemeyer H et al. (2009) Successful treatment of fulminant hepatitis B during pregnancy. Z Gastroenterol 47: 667\u2013670","journal-title":"Z Gastroenterol"},{"key":"2464_CR25","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jhep.2009.01.004","volume":"50","author":"Rizzetto","year":"2009","unstructured":"Rizzetto M (2009) Hepatitis D: thirty years after. J Hepatol 50: 1043\u20131050","journal-title":"J Hepatol"},{"key":"2464_CR26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/lt.21003","volume":"13","author":"Rosenau","year":"2007","unstructured":"Rosenau J, Hooman N, Hadem J et al. (2007) Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation. Liver Transpl 13: 367\u2013373","journal-title":"Liver Transpl"},{"key":"2464_CR27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa061847","volume":"356","author":"Shrestha","year":"2007","unstructured":"Shrestha MP, Scott RM, Joshi DM et al. (2007) Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 356: 895\u2013903","journal-title":"N Engl J Med"},{"key":"2464_CR28","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ncpgasthep0628","volume":"3","author":"Strassburg","year":"2006","unstructured":"Strassburg CP (2006) What is the influence of genotype on the success of treatment for chronic hepatitis B? Nat Clin Pract Gastroenterol Hepatol 3: 620\u2013621","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"2464_CR29","doi-asserted-by":"crossref","unstructured":"Strassburg CP, Manns MP (2009) Lebertransplantation: Indikationen und Ergebnisse. Internist (Berl) 50: 550\u2013560","DOI":"10.1007\/s00108-008-2268-8"},{"key":"2464_CR30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7326\/0003-4819-143-5-200509060-00018","volume":"143","author":"Ter","year":"2005","unstructured":"Ter Borg MJ, Janssen HL (2005) Pegylated interferon-alpha2b and lamivudine in hepatitis B e antigen-positive chronic hepatitis B. Ann Intern Med 143: 391","journal-title":"Ann Intern Med"},{"key":"2464_CR31","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0140-6736(03)14418-2","volume":"362","author":"Van","year":"2003","unstructured":"Van Damme P, Banatvala J, Fay O et al. (2003) Hepatitis A booster vaccination: is there a need? Lancet 362: 1065\u20131071","journal-title":"Lancet"},{"key":"2464_CR32","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/hep.22251","volume":"47","author":"Veldt","year":"2008","unstructured":"Veldt BJ, Chen W, Heathcote EJ et al. (2008) Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 47: 1856\u20131862","journal-title":"Hepatology"},{"key":"2464_CR33","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa070546","volume":"357","author":"Victor","year":"2007","unstructured":"Victor JC, Monto AS, Surdina TY et al. (2007) Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med 357: 1685\u20131694","journal-title":"N Engl J Med"},{"key":"2464_CR34","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2006.06.043","volume":"131","author":"Wedemeyer","year":"2006","unstructured":"Wedemeyer H, Cornberg M, Wiegand J et al. (2006) Treatment of acute hepatitis C-how to explain the differences? Gastroenterology 131: 682\u2013683","journal-title":"Gastroenterology"},{"key":"2464_CR35","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0168-8278(07)61602-X","volume":"46","author":"Wedemeyer","year":"2007","unstructured":"Wedemeyer H, Yurdaydin C, Dalekos G et al. (2007) 72 week data of the HIDIT-1 trial: A multicenter randomised study comparing peginterferon alpha-2a plus adefovir vs. peginterferon alpha-2a plus placebo vs. adefovir in chronic delta hepatitis. J Hepatol 46: S4","journal-title":"J Hepatol"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-009-2464-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-009-2464-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-009-2464-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:12:15Z","timestamp":1558584735000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-009-2464-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,18]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["2464"],"URL":"https:\/\/doi.org\/10.1007\/s00108-009-2464-1","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,18]]}}}